Salo Ooft
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 5
- Colorectal Cancer Treatments and Studies 3
- Cancer Cells and Metastasis 2
- Cytokine Signaling Pathways and Interactions 1
- Cancer Treatment and Pharmacology 1
-
- Cancer Genomics and Diagnostics 3
- Co-authors
- Emile E. Voest (5 shared papers)Fleur Weeber (2 shared papers)Krijn K. Dijkstra (2 shared papers)Chelsea McLean (2 shared papers)Joris van de Haar (2 shared papers)Louisa R. Hoes (2 shared papers)Robert R.J. Coebergh van den Braak (1 shared paper)Anieta M. Sieuwerts (1 shared paper)
- Journals
- ESMO Open (1 paper)Journal of Clinical Oncology (1 paper)Nature Communications (1 paper)Cancer Research (1 paper)Cell chemical biology (1 paper)
- Partner nations
- NetherlandsBrazilSpain
In The Last Decade
Salo Ooft
5 papers receiving 598 citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Oncology 386
- Cancer Research 186
- Biotechnology 53
- Biomedical Engineering 195
- Modeling and Simulation 15
Countries citing papers authored by Salo Ooft
This map shows the geographic impact of Salo Ooft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salo Ooft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salo Ooft more than expected).
Fields of papers citing papers by Salo Ooft
This network shows the impact of papers produced by Salo Ooft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salo Ooft. The network helps show where Salo Ooft may publish in the future.
Co-authors
The 25 scholars most cited alongside Salo Ooft, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery Hit paper breakdown → | 2017 | 381 |
| 2 | 2021 | 89 | |
| 3 | 2017 | 67 | |
| 4 | 2020 | 67 | |
| 5 | 2022 | 1 |
About Salo Ooft
Salo Ooft is a scholar working on Oncology, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 5 papers that have together received 605 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (3 papers), Cancer Genomics and Diagnostics (3 papers), Cancer Cells and Metastasis (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), Cancer Treatment and Pharmacology (1 paper), Genetic factors in colorectal cancer (1 paper) and Melanoma and MAPK Pathways (1 paper). The work is most often cited by research in Oncology (386 citations), Cancer Research (186 citations), Biotechnology (53 citations), Biomedical Engineering (195 citations) and Modeling and Simulation (15 citations). Salo Ooft has collaborated with scholars based in Netherlands, Brazil and Spain. Frequent co-authors include Emile E. Voest, Fleur Weeber, Krijn K. Dijkstra, Chelsea McLean, Joris van de Haar, Louisa R. Hoes, Robert R.J. Coebergh van den Braak, Anieta M. Sieuwerts, Fried Zwartkruis and Monique E. van Leerdam. Their work appears in journals such as ESMO Open, Journal of Clinical Oncology, Nature Communications, Cancer Research and Cell chemical biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.